Ally Invest Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Ally Invest Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Sell	3,581 -643	-15%	-$35.2K	0.01%	74
2026 Q1	$221K	Sell	4,224 -245	-5%	-$12.5K	0.01%	74
2025 Q4	$229K	Sell	4,469 -1,846	-29%	-$85.4K	0.02%	74
2025 Q3	$245K	Sell	6,315 -350	-5%	-$12K	0.02%	73
2025 Q2	$200K	Buy	+6,665	New	+$191K	0.02%	74

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Ally Invest Advisors's SBIO Position: Q2 2026 in Review

Ally Invest Advisors reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 15% in Q2 2026, selling an estimated $35.2K and leaving 3,581 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #74.

Ally Invest Advisors first reported a position in SBIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $245K in Q3 2025. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Ally Invest Advisors held 3,581 shares of ALPS Medical Breakthroughs ETF worth $232K as of Q2 2026.
Ally Invest Advisors sold 643 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $35.2K.
ALPS Medical Breakthroughs ETF made up 0.01% of Ally Invest Advisors's portfolio in Q2 2026, its #74 holding.
Ally Invest Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2025 and has held it in 5 quarters since.
Ally Invest Advisors's ALPS Medical Breakthroughs ETF position peaked at $245K in Q3 2025.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Ally Invest Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.